Explore how batch variability impacts bioequivalence standards. Learn why the 80-125% rule may be flawed and how new Between-Batch methods improve generic drug safety.
Nov, 25 2025
Feb, 3 2026
Jul, 3 2026
Jul, 23 2026
Mar, 31 2026